Global Live Cell Imaging Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 291011
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Live Cell Imaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Live Cell Imaging market size is estimated to be worth US$ 1633.8 million in 2021 and is forecast to a readjusted size of USD 2588.4 million by 2028 with a CAGR of 6.8% during review period. Hospitals accounting for % of the Live Cell Imaging global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Equipment segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Live Cell Imaging include Carl Zeiss (Germany), Leica Microsystems (Germany), Olympus (Japan), GE Healthcare (U.K.), and BD (U.S.), etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Live Cell Imaging market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Equipment

Consumables

Software

Market segment by Application, can be divided into

Hospitals

Pharmaceutical Companies

Biotechnological Companies

Diagnostic Laboratories

Others

Market segment by players, this report covers

Carl Zeiss (Germany)

Leica Microsystems (Germany)

Olympus (Japan)

GE Healthcare (U.K.)

BD (U.S.)

Thermo Fisher Scientific (U.S.)

Danaher (U.S.)

Sigma-Aldrich (U.S.)

Nikon (Japan)

Molecular Devices (U.S.)

PerkinElmer (U.S.)

BioTek Instruments (U.S.)

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Live Cell Imaging product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Live Cell Imaging, with revenue, gross margin and global market share of Live Cell Imaging from 2019 to 2022.

Chapter 3, the Live Cell Imaging competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Live Cell Imaging market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Live Cell Imaging research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Live Cell Imaging

1.2 Classification of Live Cell Imaging by Type

1.2.1 Overview: Global Live Cell Imaging Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Live Cell Imaging Revenue Market Share by Type in 2021

1.2.3 Equipment

1.2.4 Consumables

1.2.5 Software

1.3 Global Live Cell Imaging Market by Application

1.3.1 Overview: Global Live Cell Imaging Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Pharmaceutical Companies

1.3.4 Biotechnological Companies

1.3.5 Diagnostic Laboratories

1.3.6 Others

1.4 Global Live Cell Imaging Market Size & Forecast

1.5 Global Live Cell Imaging Market Size and Forecast by Region

1.5.1 Global Live Cell Imaging Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Live Cell Imaging Market Size by Region, (2017-2022)

1.5.3 North America Live Cell Imaging Market Size and Prospect (2017-2028)

1.5.4 Europe Live Cell Imaging Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Live Cell Imaging Market Size and Prospect (2017-2028)

1.5.6 South America Live Cell Imaging Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Live Cell Imaging Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Live Cell Imaging Market Drivers

1.6.2 Live Cell Imaging Market Restraints

1.6.3 Live Cell Imaging Trends Analysis

2 Company Profiles

2.1 Carl Zeiss (Germany)

2.1.1 Carl Zeiss (Germany) Details

2.1.2 Carl Zeiss (Germany) Major Business

2.1.3 Carl Zeiss (Germany) Live Cell Imaging Product and Solutions

2.1.4 Carl Zeiss (Germany) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Carl Zeiss (Germany) Recent Developments and Future Plans

2.2 Leica Microsystems (Germany)

2.2.1 Leica Microsystems (Germany) Details

2.2.2 Leica Microsystems (Germany) Major Business

2.2.3 Leica Microsystems (Germany) Live Cell Imaging Product and Solutions

2.2.4 Leica Microsystems (Germany) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Leica Microsystems (Germany) Recent Developments and Future Plans

2.3 Olympus (Japan)

2.3.1 Olympus (Japan) Details

2.3.2 Olympus (Japan) Major Business

2.3.3 Olympus (Japan) Live Cell Imaging Product and Solutions

2.3.4 Olympus (Japan) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Olympus (Japan) Recent Developments and Future Plans

2.4 GE Healthcare (U.K.)

2.4.1 GE Healthcare (U.K.) Details

2.4.2 GE Healthcare (U.K.) Major Business

2.4.3 GE Healthcare (U.K.) Live Cell Imaging Product and Solutions

2.4.4 GE Healthcare (U.K.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 GE Healthcare (U.K.) Recent Developments and Future Plans

2.5 BD (U.S.)

2.5.1 BD (U.S.) Details

2.5.2 BD (U.S.) Major Business

2.5.3 BD (U.S.) Live Cell Imaging Product and Solutions

2.5.4 BD (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 BD (U.S.) Recent Developments and Future Plans

2.6 Thermo Fisher Scientific (U.S.)

2.6.1 Thermo Fisher Scientific (U.S.) Details

2.6.2 Thermo Fisher Scientific (U.S.) Major Business

2.6.3 Thermo Fisher Scientific (U.S.) Live Cell Imaging Product and Solutions

2.6.4 Thermo Fisher Scientific (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Thermo Fisher Scientific (U.S.) Recent Developments and Future Plans

2.7 Danaher (U.S.)

2.7.1 Danaher (U.S.) Details

2.7.2 Danaher (U.S.) Major Business

2.7.3 Danaher (U.S.) Live Cell Imaging Product and Solutions

2.7.4 Danaher (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Danaher (U.S.) Recent Developments and Future Plans

2.8 Sigma-Aldrich (U.S.)

2.8.1 Sigma-Aldrich (U.S.) Details

2.8.2 Sigma-Aldrich (U.S.) Major Business

2.8.3 Sigma-Aldrich (U.S.) Live Cell Imaging Product and Solutions

2.8.4 Sigma-Aldrich (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sigma-Aldrich (U.S.) Recent Developments and Future Plans

2.9 Nikon (Japan)

2.9.1 Nikon (Japan) Details

2.9.2 Nikon (Japan) Major Business

2.9.3 Nikon (Japan) Live Cell Imaging Product and Solutions

2.9.4 Nikon (Japan) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Nikon (Japan) Recent Developments and Future Plans

2.10 Molecular Devices (U.S.)

2.10.1 Molecular Devices (U.S.) Details

2.10.2 Molecular Devices (U.S.) Major Business

2.10.3 Molecular Devices (U.S.) Live Cell Imaging Product and Solutions

2.10.4 Molecular Devices (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Molecular Devices (U.S.) Recent Developments and Future Plans

2.11 PerkinElmer (U.S.)

2.11.1 PerkinElmer (U.S.) Details

2.11.2 PerkinElmer (U.S.) Major Business

2.11.3 PerkinElmer (U.S.) Live Cell Imaging Product and Solutions

2.11.4 PerkinElmer (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 PerkinElmer (U.S.) Recent Developments and Future Plans

2.12 BioTek Instruments (U.S.)

2.12.1 BioTek Instruments (U.S.) Details

2.12.2 BioTek Instruments (U.S.) Major Business

2.12.3 BioTek Instruments (U.S.) Live Cell Imaging Product and Solutions

2.12.4 BioTek Instruments (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 BioTek Instruments (U.S.) Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Live Cell Imaging Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Live Cell Imaging Players Market Share in 2021

3.2.2 Top 10 Live Cell Imaging Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Live Cell Imaging Players Head Office, Products and Services Provided

3.4 Live Cell Imaging Mergers & Acquisitions

3.5 Live Cell Imaging New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Live Cell Imaging Revenue and Market Share by Type (2017-2022)

4.2 Global Live Cell Imaging Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Live Cell Imaging Revenue Market Share by Application (2017-2022)

5.2 Global Live Cell Imaging Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Live Cell Imaging Revenue by Type (2017-2028)

6.2 North America Live Cell Imaging Revenue by Application (2017-2028)

6.3 North America Live Cell Imaging Market Size by Country

6.3.1 North America Live Cell Imaging Revenue by Country (2017-2028)

6.3.2 United States Live Cell Imaging Market Size and Forecast (2017-2028)

6.3.3 Canada Live Cell Imaging Market Size and Forecast (2017-2028)

6.3.4 Mexico Live Cell Imaging Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Live Cell Imaging Revenue by Type (2017-2028)

7.2 Europe Live Cell Imaging Revenue by Application (2017-2028)

7.3 Europe Live Cell Imaging Market Size by Country

7.3.1 Europe Live Cell Imaging Revenue by Country (2017-2028)

7.3.2 Germany Live Cell Imaging Market Size and Forecast (2017-2028)

7.3.3 France Live Cell Imaging Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Live Cell Imaging Market Size and Forecast (2017-2028)

7.3.5 Russia Live Cell Imaging Market Size and Forecast (2017-2028)

7.3.6 Italy Live Cell Imaging Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Live Cell Imaging Revenue by Type (2017-2028)

8.2 Asia-Pacific Live Cell Imaging Revenue by Application (2017-2028)

8.3 Asia-Pacific Live Cell Imaging Market Size by Region

8.3.1 Asia-Pacific Live Cell Imaging Revenue by Region (2017-2028)

8.3.2 China Live Cell Imaging Market Size and Forecast (2017-2028)

8.3.3 Japan Live Cell Imaging Market Size and Forecast (2017-2028)

8.3.4 South Korea Live Cell Imaging Market Size and Forecast (2017-2028)

8.3.5 India Live Cell Imaging Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Live Cell Imaging Market Size and Forecast (2017-2028)

8.3.7 Australia Live Cell Imaging Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Live Cell Imaging Revenue by Type (2017-2028)

9.2 South America Live Cell Imaging Revenue by Application (2017-2028)

9.3 South America Live Cell Imaging Market Size by Country

9.3.1 South America Live Cell Imaging Revenue by Country (2017-2028)

9.3.2 Brazil Live Cell Imaging Market Size and Forecast (2017-2028)

9.3.3 Argentina Live Cell Imaging Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Live Cell Imaging Revenue by Type (2017-2028)

10.2 Middle East & Africa Live Cell Imaging Revenue by Application (2017-2028)

10.3 Middle East & Africa Live Cell Imaging Market Size by Country

10.3.1 Middle East & Africa Live Cell Imaging Revenue by Country (2017-2028)

10.3.2 Turkey Live Cell Imaging Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Live Cell Imaging Market Size and Forecast (2017-2028)

10.3.4 UAE Live Cell Imaging Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Live Cell Imaging Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Live Cell Imaging Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Live Cell Imaging Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Live Cell Imaging Revenue (USD Million) by Region (2017-2022)

Table 5. Global Live Cell Imaging Revenue Market Share by Region (2023-2028)

Table 6. Carl Zeiss (Germany) Corporate Information, Head Office, and Major Competitors

Table 7. Carl Zeiss (Germany) Major Business

Table 8. Carl Zeiss (Germany) Live Cell Imaging Product and Solutions

Table 9. Carl Zeiss (Germany) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Leica Microsystems (Germany) Corporate Information, Head Office, and Major Competitors

Table 11. Leica Microsystems (Germany) Major Business

Table 12. Leica Microsystems (Germany) Live Cell Imaging Product and Solutions

Table 13. Leica Microsystems (Germany) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Olympus (Japan) Corporate Information, Head Office, and Major Competitors

Table 15. Olympus (Japan) Major Business

Table 16. Olympus (Japan) Live Cell Imaging Product and Solutions

Table 17. Olympus (Japan) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. GE Healthcare (U.K.) Corporate Information, Head Office, and Major Competitors

Table 19. GE Healthcare (U.K.) Major Business

Table 20. GE Healthcare (U.K.) Live Cell Imaging Product and Solutions

Table 21. GE Healthcare (U.K.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. BD (U.S.) Corporate Information, Head Office, and Major Competitors

Table 23. BD (U.S.) Major Business

Table 24. BD (U.S.) Live Cell Imaging Product and Solutions

Table 25. BD (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Thermo Fisher Scientific (U.S.) Corporate Information, Head Office, and Major Competitors

Table 27. Thermo Fisher Scientific (U.S.) Major Business

Table 28. Thermo Fisher Scientific (U.S.) Live Cell Imaging Product and Solutions

Table 29. Thermo Fisher Scientific (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Danaher (U.S.) Corporate Information, Head Office, and Major Competitors

Table 31. Danaher (U.S.) Major Business

Table 32. Danaher (U.S.) Live Cell Imaging Product and Solutions

Table 33. Danaher (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sigma-Aldrich (U.S.) Corporate Information, Head Office, and Major Competitors

Table 35. Sigma-Aldrich (U.S.) Major Business

Table 36. Sigma-Aldrich (U.S.) Live Cell Imaging Product and Solutions

Table 37. Sigma-Aldrich (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Nikon (Japan) Corporate Information, Head Office, and Major Competitors

Table 39. Nikon (Japan) Major Business

Table 40. Nikon (Japan) Live Cell Imaging Product and Solutions

Table 41. Nikon (Japan) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Molecular Devices (U.S.) Corporate Information, Head Office, and Major Competitors

Table 43. Molecular Devices (U.S.) Major Business

Table 44. Molecular Devices (U.S.) Live Cell Imaging Product and Solutions

Table 45. Molecular Devices (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. PerkinElmer (U.S.) Corporate Information, Head Office, and Major Competitors

Table 47. PerkinElmer (U.S.) Major Business

Table 48. PerkinElmer (U.S.) Live Cell Imaging Product and Solutions

Table 49. PerkinElmer (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. BioTek Instruments (U.S.) Corporate Information, Head Office, and Major Competitors

Table 51. BioTek Instruments (U.S.) Major Business

Table 52. BioTek Instruments (U.S.) Live Cell Imaging Product and Solutions

Table 53. BioTek Instruments (U.S.) Live Cell Imaging Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Global Live Cell Imaging Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 55. Global Live Cell Imaging Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 56. Breakdown of Live Cell Imaging by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Live Cell Imaging Players Head Office, Products and Services Provided

Table 58. Live Cell Imaging Mergers & Acquisitions in the Past Five Years

Table 59. Live Cell Imaging New Entrants and Expansion Plans

Table 60. Global Live Cell Imaging Revenue (USD Million) by Type (2017-2022)

Table 61. Global Live Cell Imaging Revenue Share by Type (2017-2022)

Table 62. Global Live Cell Imaging Revenue Forecast by Type (2023-2028)

Table 63. Global Live Cell Imaging Revenue by Application (2017-2022)

Table 64. Global Live Cell Imaging Revenue Forecast by Application (2023-2028)

Table 65. North America Live Cell Imaging Revenue by Type (2017-2022) & (USD Million)

Table 66. North America Live Cell Imaging Revenue by Type (2023-2028) & (USD Million)

Table 67. North America Live Cell Imaging Revenue by Application (2017-2022) & (USD Million)

Table 68. North America Live Cell Imaging Revenue by Application (2023-2028) & (USD Million)

Table 69. North America Live Cell Imaging Revenue by Country (2017-2022) & (USD Million)

Table 70. North America Live Cell Imaging Revenue by Country (2023-2028) & (USD Million)

Table 71. Europe Live Cell Imaging Revenue by Type (2017-2022) & (USD Million)

Table 72. Europe Live Cell Imaging Revenue by Type (2023-2028) & (USD Million)

Table 73. Europe Live Cell Imaging Revenue by Application (2017-2022) & (USD Million)

Table 74. Europe Live Cell Imaging Revenue by Application (2023-2028) & (USD Million)

Table 75. Europe Live Cell Imaging Revenue by Country (2017-2022) & (USD Million)

Table 76. Europe Live Cell Imaging Revenue by Country (2023-2028) & (USD Million)

Table 77. Asia-Pacific Live Cell Imaging Revenue by Type (2017-2022) & (USD Million)

Table 78. Asia-Pacific Live Cell Imaging Revenue by Type (2023-2028) & (USD Million)

Table 79. Asia-Pacific Live Cell Imaging Revenue by Application (2017-2022) & (USD Million)

Table 80. Asia-Pacific Live Cell Imaging Revenue by Application (2023-2028) & (USD Million)

Table 81. Asia-Pacific Live Cell Imaging Revenue by Region (2017-2022) & (USD Million)

Table 82. Asia-Pacific Live Cell Imaging Revenue by Region (2023-2028) & (USD Million)

Table 83. South America Live Cell Imaging Revenue by Type (2017-2022) & (USD Million)

Table 84. South America Live Cell Imaging Revenue by Type (2023-2028) & (USD Million)

Table 85. South America Live Cell Imaging Revenue by Application (2017-2022) & (USD Million)

Table 86. South America Live Cell Imaging Revenue by Application (2023-2028) & (USD Million)

Table 87. South America Live Cell Imaging Revenue by Country (2017-2022) & (USD Million)

Table 88. South America Live Cell Imaging Revenue by Country (2023-2028) & (USD Million)

Table 89. Middle East & Africa Live Cell Imaging Revenue by Type (2017-2022) & (USD Million)

Table 90. Middle East & Africa Live Cell Imaging Revenue by Type (2023-2028) & (USD Million)

Table 91. Middle East & Africa Live Cell Imaging Revenue by Application (2017-2022) & (USD Million)

Table 92. Middle East & Africa Live Cell Imaging Revenue by Application (2023-2028) & (USD Million)

Table 93. Middle East & Africa Live Cell Imaging Revenue by Country (2017-2022) & (USD Million)

Table 94. Middle East & Africa Live Cell Imaging Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Live Cell Imaging Picture

Figure 2. Global Live Cell Imaging Revenue Market Share by Type in 2021

Figure 3. Equipment

Figure 4. Consumables

Figure 5. Software

Figure 6. Live Cell Imaging Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Pharmaceutical Companies Picture

Figure 9. Biotechnological Companies Picture

Figure 10. Diagnostic Laboratories Picture

Figure 11. Others Picture

Figure 12. Global Live Cell Imaging Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 13. Global Live Cell Imaging Revenue and Forecast (2017-2028) & (USD Million)

Figure 14. Global Live Cell Imaging Revenue Market Share by Region (2017-2028)

Figure 15. Global Live Cell Imaging Revenue Market Share by Region in 2021

Figure 16. North America Live Cell Imaging Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. Europe Live Cell Imaging Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Asia-Pacific Live Cell Imaging Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. South America Live Cell Imaging Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. Middle East and Africa Live Cell Imaging Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Live Cell Imaging Market Drivers

Figure 22. Live Cell Imaging Market Restraints

Figure 23. Live Cell Imaging Market Trends

Figure 24. Carl Zeiss (Germany) Recent Developments and Future Plans

Figure 25. Leica Microsystems (Germany) Recent Developments and Future Plans

Figure 26. Olympus (Japan) Recent Developments and Future Plans

Figure 27. GE Healthcare (U.K.) Recent Developments and Future Plans

Figure 28. BD (U.S.) Recent Developments and Future Plans

Figure 29. Thermo Fisher Scientific (U.S.) Recent Developments and Future Plans

Figure 30. Danaher (U.S.) Recent Developments and Future Plans

Figure 31. Sigma-Aldrich (U.S.) Recent Developments and Future Plans

Figure 32. Nikon (Japan) Recent Developments and Future Plans

Figure 33. Molecular Devices (U.S.) Recent Developments and Future Plans

Figure 34. PerkinElmer (U.S.) Recent Developments and Future Plans

Figure 35. BioTek Instruments (U.S.) Recent Developments and Future Plans

Figure 36. Global Live Cell Imaging Revenue Share by Players in 2021

Figure 37. Live Cell Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 38. Global Top 3 Players Live Cell Imaging Revenue Market Share in 2021

Figure 39. Global Top 10 Players Live Cell Imaging Revenue Market Share in 2021

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 41. Global Live Cell Imaging Revenue Share by Type in 2021

Figure 42. Global Live Cell Imaging Market Share Forecast by Type (2023-2028)

Figure 43. Global Live Cell Imaging Revenue Share by Application in 2021

Figure 44. Global Live Cell Imaging Market Share Forecast by Application (2023-2028)

Figure 45. North America Live Cell Imaging Sales Market Share by Type (2017-2028)

Figure 46. North America Live Cell Imaging Sales Market Share by Application (2017-2028)

Figure 47. North America Live Cell Imaging Revenue Market Share by Country (2017-2028)

Figure 48. United States Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Canada Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Mexico Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Europe Live Cell Imaging Sales Market Share by Type (2017-2028)

Figure 52. Europe Live Cell Imaging Sales Market Share by Application (2017-2028)

Figure 53. Europe Live Cell Imaging Revenue Market Share by Country (2017-2028)

Figure 54. Germany Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. France Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. United Kingdom Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Russia Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Italy Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Asia-Pacific Live Cell Imaging Sales Market Share by Type (2017-2028)

Figure 60. Asia-Pacific Live Cell Imaging Sales Market Share by Application (2017-2028)

Figure 61. Asia-Pacific Live Cell Imaging Revenue Market Share by Region (2017-2028)

Figure 62. China Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. South Korea Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Live Cell Imaging Sales Market Share by Type (2017-2028)

Figure 69. South America Live Cell Imaging Sales Market Share by Application (2017-2028)

Figure 70. South America Live Cell Imaging Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East and Africa Live Cell Imaging Sales Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Live Cell Imaging Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Live Cell Imaging Revenue Market Share by Country (2017-2028)

Figure 76. Turkey Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Saudi Arabia Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. UAE Live Cell Imaging Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source